25 XP   0   0   10

Wuhan Thalys Med Tech Co Ltd
Buy, Hold or Sell?

Let's analyse Thalys together

PenkeI guess you are interested in Wuhan Thalys Med Tech Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Wuhan Thalys Med Tech Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Wuhan Thalys Med Tech Co Ltd

I send you an email if I find something interesting about Wuhan Thalys Med Tech Co Ltd.

Quick analysis of Thalys (30 sec.)










What can you expect buying and holding a share of Thalys? (30 sec.)

How much money do you get?

How much money do you get?
¥0.14
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥7.36
Expected worth in 1 year
¥2.77
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
¥-3.56
Return On Investment
-54.8%

For what price can you sell your share?

Current Price per Share
¥6.49
Expected price per share
¥5.2 - ¥11.46
How sure are you?
50%

1. Valuation of Thalys (5 min.)




Live pricePrice per Share (EOD)

¥6.49

Intrinsic Value Per Share

¥-5.50 - ¥3.53

Total Value Per Share

¥1.86 - ¥10.88

2. Growth of Thalys (5 min.)




Is Thalys growing?

Current yearPrevious yearGrowGrow %
How rich?$206.8m$240.8m-$33.9m-16.4%

How much money is Thalys making?

Current yearPrevious yearGrowGrow %
Making money-$21.3m-$6.8m-$14.4m-67.9%
Net Profit Margin-6.7%-1.9%--

How much money comes from the company's main activities?

3. Financial Health of Thalys (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#57 / 146

Most Revenue
#38 / 146

Most Profit
#119 / 146

What can you expect buying and holding a share of Thalys? (5 min.)

Welcome investor! Thalys's management wants to use your money to grow the business. In return you get a share of Thalys.

What can you expect buying and holding a share of Thalys?

First you should know what it really means to hold a share of Thalys. And how you can make/lose money.

Speculation

The Price per Share of Thalys is ¥6.49. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Thalys.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Thalys, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.36. Based on the TTM, the Book Value Change Per Share is ¥-1.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.26 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Thalys.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.10-1.6%-0.10-1.6%-0.03-0.5%0.010.1%0.020.3%
Usd Book Value Change Per Share-0.16-2.4%-0.16-2.4%-0.04-0.6%0.071.0%0.081.3%
Usd Dividend Per Share0.040.5%0.040.5%0.030.5%0.030.5%0.020.3%
Usd Total Gains Per Share-0.12-1.9%-0.12-1.9%-0.01-0.1%0.101.5%0.101.6%
Usd Price Per Share1.53-1.53-1.99-2.15-3.02-
Price to Earnings Ratio-14.55--14.55--59.59-11.47-43.69-
Price-to-Total Gains Ratio-12.42--12.42--293.71--42.00--15.53-
Price to Book Ratio1.50-1.50-1.69-1.92-4.12-
Price-to-Total Gains Ratio-12.42--12.42--293.71--42.00--15.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.896918
Number of shares1114
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share-0.160.07
Usd Total Gains Per Share-0.120.10
Gains per Quarter (1114 shares)-136.86110.32
Gains per Year (1114 shares)-547.45441.27
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1158-706-557149292431
2316-1411-1104299584872
3474-2117-16514488761313
4632-2822-219859811671754
5791-3528-274574714592195
6949-4233-329289717512636
71107-4939-3839104620433077
81265-5644-4386119523353518
91423-6350-4933134526273959
101581-7056-5480149429194400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%6.02.02.060.0%6.02.04.050.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%9.03.00.075.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.02.083.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%10.02.00.083.3%

Fundamentals of Thalys

About Wuhan Thalys Med Tech Co Ltd

Thalys Medical Technology Group Corporation provides intensive operation services of medical inspection in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.

Fundamental data was last updated by Penke on 2024-04-18 13:48:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Wuhan Thalys Med Tech Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Thalys earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -6.7% means that ¥-0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is -6.7%. The company is making a loss. -1
  • The TTM is -6.7%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-6.7%TTM-6.7%0.0%
TTM-6.7%YOY-1.9%-4.8%
TTM-6.7%5Y1.5%-8.1%
5Y1.5%10Y2.8%-1.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.7%-7.2%+0.5%
TTM-6.7%-6.3%-0.4%
YOY-1.9%1.3%-3.2%
5Y1.5%-2.2%+3.7%
10Y2.8%-1.4%+4.2%
1.1.2. Return on Assets

Shows how efficient Thalys is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • -3.9% Return on Assets means that Thalys generated ¥-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is -3.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.9%TTM-3.9%0.0%
TTM-3.9%YOY-1.2%-2.8%
TTM-3.9%5Y0.7%-4.7%
5Y0.7%10Y1.6%-0.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.9%-1.5%-2.4%
TTM-3.9%-1.2%-2.7%
YOY-1.2%-0.6%-0.6%
5Y0.7%-0.6%+1.3%
10Y1.6%-0.9%+2.5%
1.1.3. Return on Equity

Shows how efficient Thalys is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • -11.0% Return on Equity means Thalys generated ¥-0.11 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is -11.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.0%TTM-11.0%0.0%
TTM-11.0%YOY-3.2%-7.8%
TTM-11.0%5Y0.6%-11.6%
5Y0.6%10Y2.1%-1.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.0%-0.5%-10.5%
TTM-11.0%--11.0%
YOY-3.2%0.3%-3.5%
5Y0.6%-1.5%+2.1%
10Y2.1%-2.5%+4.6%

1.2. Operating Efficiency of Wuhan Thalys Med Tech Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Thalys is operating .

  • Measures how much profit Thalys makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • An Operating Margin of 3.4% means the company generated ¥0.03  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 3.4%. The company is operating less efficient.
  • The TTM is 3.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.4%TTM3.4%0.0%
TTM3.4%YOY3.6%-0.3%
TTM3.4%5Y8.3%-5.0%
5Y8.3%10Y7.9%+0.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4%-6.2%+9.6%
TTM3.4%-5.8%+9.2%
YOY3.6%4.8%-1.2%
5Y8.3%1.6%+6.7%
10Y7.9%-2.0%+9.9%
1.2.2. Operating Ratio

Measures how efficient Thalys is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.77 means that the operating costs are ¥1.77 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 1.768. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.768. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.768TTM1.7680.000
TTM1.768YOY1.726+0.042
TTM1.7685Y1.655+0.113
5Y1.65510Y1.298+0.357
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7681.310+0.458
TTM1.7681.303+0.465
YOY1.7261.240+0.486
5Y1.6551.270+0.385
10Y1.2981.228+0.070

1.3. Liquidity of Wuhan Thalys Med Tech Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Thalys is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.61 means the company has ¥1.61 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 1.607. The company is able to pay all its short-term debts. +1
  • The TTM is 1.607. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.607TTM1.6070.000
TTM1.607YOY1.867-0.260
TTM1.6075Y1.872-0.265
5Y1.87210Y1.574+0.297
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6072.194-0.587
TTM1.6072.366-0.759
YOY1.8672.753-0.886
5Y1.8722.989-1.117
10Y1.5743.000-1.426
1.3.2. Quick Ratio

Measures if Thalys is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.96 means the company can pay off ¥0.96 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 0.962. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.962. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.962TTM0.9620.000
TTM0.962YOY1.016-0.054
TTM0.9625Y1.000-0.038
5Y1.00010Y1.507-0.507
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9621.273-0.311
TTM0.9621.355-0.393
YOY1.0161.563-0.547
5Y1.0001.952-0.952
10Y1.5072.127-0.620

1.4. Solvency of Wuhan Thalys Med Tech Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Thalys assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Thalys to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.62 means that Thalys assets are financed with 62.1% credit (debt) and the remaining percentage (100% - 62.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 0.621. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.621. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.621TTM0.6210.000
TTM0.621YOY0.594+0.027
TTM0.6215Y0.517+0.104
5Y0.51710Y0.390+0.127
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6210.425+0.196
TTM0.6210.411+0.210
YOY0.5940.393+0.201
5Y0.5170.450+0.067
10Y0.3900.448-0.058
1.4.2. Debt to Equity Ratio

Measures if Thalys is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 174.7% means that company has ¥1.75 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 1.747. The company is just able to pay all its debts with equity.
  • The TTM is 1.747. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.747TTM1.7470.000
TTM1.747YOY1.633+0.114
TTM1.7475Y1.243+0.503
5Y1.24310Y0.812+0.432
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7470.606+1.141
TTM1.7470.571+1.176
YOY1.6330.606+1.027
5Y1.2430.637+0.606
10Y0.8120.730+0.082

2. Market Valuation of Wuhan Thalys Med Tech Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Thalys generates.

  • Above 15 is considered overpriced but always compare Thalys to the Diagnostics & Research industry mean.
  • A PE ratio of -14.55 means the investor is paying ¥-14.55 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The EOD is -8.554. Based on the earnings, the company is expensive. -2
  • The MRQ is -14.550. Based on the earnings, the company is expensive. -2
  • The TTM is -14.550. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.554MRQ-14.550+5.997
MRQ-14.550TTM-14.5500.000
TTM-14.550YOY-59.594+45.043
TTM-14.5505Y11.472-26.022
5Y11.47210Y43.689-32.217
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-8.554-0.202-8.352
MRQ-14.550-0.402-14.148
TTM-14.550-0.119-14.431
YOY-59.594-0.003-59.591
5Y11.4722.211+9.261
10Y43.6894.907+38.782
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The EOD is -49.802. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -84.717. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -84.717. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-49.802MRQ-84.717+34.915
MRQ-84.717TTM-84.7170.000
TTM-84.717YOY-15.230-69.487
TTM-84.7175Y-299.921+215.204
5Y-299.92110Y-177.998-121.922
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-49.802-0.179-49.623
MRQ-84.717-0.417-84.300
TTM-84.717-1.288-83.429
YOY-15.230-2.547-12.683
5Y-299.921-1.999-297.922
10Y-177.998-2.372-175.626
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Thalys is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.50 means the investor is paying ¥1.50 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The EOD is 0.882. Based on the equity, the company is cheap. +2
  • The MRQ is 1.501. Based on the equity, the company is underpriced. +1
  • The TTM is 1.501. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.882MRQ1.501-0.619
MRQ1.501TTM1.5010.000
TTM1.501YOY1.693-0.192
TTM1.5015Y1.921-0.420
5Y1.92110Y4.118-2.196
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.8821.877-0.995
MRQ1.5012.437-0.936
TTM1.5012.235-0.734
YOY1.6933.239-1.546
5Y1.9213.450-1.529
10Y4.1184.040+0.078
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Wuhan Thalys Med Tech Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.146-1.1460%-0.291-75%0.474-342%0.588-295%
Book Value Per Share--7.3567.3560%8.501-13%8.095-9%5.580+32%
Current Ratio--1.6071.6070%1.867-14%1.872-14%1.574+2%
Debt To Asset Ratio--0.6210.6210%0.594+4%0.517+20%0.390+59%
Debt To Equity Ratio--1.7471.7470%1.633+7%1.243+40%0.812+115%
Dividend Per Share--0.2570.2570%0.242+6%0.243+6%0.140+83%
Eps---0.759-0.7590%-0.241-68%0.056-1466%0.139-645%
Free Cash Flow Per Share---0.130-0.1300%-0.945+625%-0.510+292%-0.386+196%
Free Cash Flow To Equity Per Share---1.686-1.6860%-0.645-62%0.430-492%0.359-569%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.700+43%
Intrinsic Value_10Y_max--3.525--------
Intrinsic Value_10Y_min---5.498--------
Intrinsic Value_1Y_max---0.227--------
Intrinsic Value_1Y_min---0.556--------
Intrinsic Value_3Y_max---0.240--------
Intrinsic Value_3Y_min---1.676--------
Intrinsic Value_5Y_max--0.281--------
Intrinsic Value_5Y_min---2.793--------
Market Cap1306586321.920-72%2246828905.4402246828905.4400%2950223309.270-24%3188520827.844-30%4421797770.220-49%
Net Profit Margin---0.067-0.0670%-0.019-72%0.015-559%0.028-335%
Operating Margin--0.0340.0340%0.036-8%0.083-60%0.079-58%
Operating Ratio--1.7681.7680%1.726+2%1.655+7%1.298+36%
Pb Ratio0.882-70%1.5011.5010%1.693-11%1.921-22%4.118-64%
Pe Ratio-8.554+41%-14.550-14.5500%-59.594+310%11.472-227%43.689-133%
Price Per Share6.490-70%11.04011.0400%14.390-23%15.564-29%21.827-49%
Price To Free Cash Flow Ratio-49.802+41%-84.717-84.7170%-15.230-82%-299.921+254%-177.998+110%
Price To Total Gains Ratio-7.301+41%-12.419-12.4190%-293.712+2265%-41.998+238%-15.528+25%
Quick Ratio--0.9620.9620%1.016-5%1.000-4%1.507-36%
Return On Assets---0.039-0.0390%-0.012-71%0.007-625%0.016-344%
Return On Equity---0.110-0.1100%-0.032-71%0.006-1982%0.021-620%
Total Gains Per Share---0.889-0.8890%-0.049-94%0.717-224%0.728-222%
Usd Book Value--206881430.014206881430.0140%240870381.279-14%229110311.414-10%157194285.169+32%
Usd Book Value Change Per Share---0.158-0.1580%-0.040-75%0.065-342%0.081-295%
Usd Book Value Per Share--1.0171.0170%1.175-13%1.119-9%0.771+32%
Usd Dividend Per Share--0.0350.0350%0.033+6%0.034+6%0.019+83%
Usd Eps---0.105-0.1050%-0.033-68%0.008-1466%0.019-645%
Usd Free Cash Flow---3665284.231-3665284.2310%-26770980.026+630%-14453800.128+294%-10863743.908+196%
Usd Free Cash Flow Per Share---0.018-0.0180%-0.131+625%-0.071+292%-0.053+196%
Usd Free Cash Flow To Equity Per Share---0.233-0.2330%-0.089-62%0.059-492%0.050-569%
Usd Market Cap180570229.689-72%310511754.732310511754.7320%407720861.341-24%440653578.408-30%611092451.844-49%
Usd Price Per Share0.897-70%1.5261.5260%1.989-23%2.151-29%3.016-49%
Usd Profit---21340461.186-21340461.1860%-6841688.214-68%1609148.905-1426%3053990.206-799%
Usd Revenue--319052894.765319052894.7650%359257443.518-11%281426839.140+13%180994982.656+76%
Usd Total Gains Per Share---0.123-0.1230%-0.007-94%0.099-224%0.101-222%
 EOD+3 -5MRQTTM+0 -0YOY+9 -265Y+10 -2510Y+15 -21

3.2. Fundamental Score

Let's check the fundamental score of Wuhan Thalys Med Tech Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.554
Price to Book Ratio (EOD)Between0-10.882
Net Profit Margin (MRQ)Greater than0-0.067
Operating Margin (MRQ)Greater than00.034
Quick Ratio (MRQ)Greater than10.962
Current Ratio (MRQ)Greater than11.607
Debt to Asset Ratio (MRQ)Less than10.621
Debt to Equity Ratio (MRQ)Less than11.747
Return on Equity (MRQ)Greater than0.15-0.110
Return on Assets (MRQ)Greater than0.05-0.039
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Wuhan Thalys Med Tech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.137
Ma 20Greater thanMa 507.954
Ma 50Greater thanMa 1007.731
Ma 100Greater thanMa 2009.437
OpenGreater thanClose6.650
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
EBITDA  246,00454,011300,014-57,624242,390-87,440154,950-163,551-8,601
Tax Provision  40,0173,78743,805-17,75826,047-11,77614,271-14,726-456
Income Tax Expense  40,0173,78743,805-17,75826,047-11,77614,271-14,726-456



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,947,451
Total Liabilities2,450,480
Total Stockholder Equity1,402,964
 As reported
Total Liabilities 2,450,480
Total Stockholder Equity+ 1,402,964
Total Assets = 3,947,451

Assets

Total Assets3,947,451
Total Current Assets2,950,563
Long-term Assets996,888
Total Current Assets
Cash And Cash Equivalents 394,544
Net Receivables 1,767,063
Inventory 420,747
Other Current Assets 113,796
Total Current Assets  (as reported)2,950,563
Total Current Assets  (calculated)2,696,150
+/- 254,413
Long-term Assets
Property Plant Equipment 233,939
Goodwill 142,413
Intangible Assets 29,817
Other Assets 257,677
Long-term Assets  (as reported)996,888
Long-term Assets  (calculated)663,846
+/- 333,042

Liabilities & Shareholders' Equity

Total Current Liabilities1,836,434
Long-term Liabilities614,046
Total Stockholder Equity1,402,964
Total Current Liabilities
Short Long Term Debt 778,870
Accounts payable 724,882
Other Current Liabilities 210,584
Total Current Liabilities  (as reported)1,836,434
Total Current Liabilities  (calculated)1,714,336
+/- 122,098
Long-term Liabilities
Long term Debt 527,369
Capital Lease Obligations Min Short Term Debt31,743
Other Liabilities 54,934
Long-term Liabilities Other 14,432
Deferred Long Term Liability 31,456
Long-term Liabilities  (as reported)614,046
Long-term Liabilities  (calculated)659,934
+/- 45,889
Total Stockholder Equity
Common Stock203,517
Retained Earnings 457,041
Other Stockholders Equity 96,178
Total Stockholder Equity (as reported)1,402,964
Total Stockholder Equity (calculated)756,736
+/- 646,227
Other
Capital Stock203,517
Common Stock Shares Outstanding 203,517
Net Debt 911,695
Net Invested Capital 2,709,202
Net Tangible Assets 1,230,734
Net Working Capital 1,114,129
Property Plant and Equipment Gross 233,939



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
314,157
388,797
437,791
537,573
663,267
1,092,481
1,569,391
2,582,812
3,007,056
3,906,340
4,293,574
3,947,451
3,947,4514,293,5743,906,3403,007,0562,582,8121,569,3911,092,481663,267537,573437,791388,797314,157
   > Total Current Assets 
0
0
0
0
0
889,788
1,109,323
1,951,028
2,229,120
2,928,180
3,242,033
2,950,563
2,950,5633,242,0332,928,1802,229,1201,951,0281,109,323889,78800000
       Cash And Cash Equivalents 
64,118
50,910
50,159
66,492
96,718
353,784
196,500
702,879
508,112
661,753
473,550
394,544
394,544473,550661,753508,112702,879196,500353,78496,71866,49250,15950,91064,118
       Short-term Investments 
0
0
0
0
0
0
500
0
2,000
0
12,000
0
012,00002,0000500000000
       Net Receivables 
119,675
143,855
200,767
260,264
310,371
403,540
612,370
898,754
1,279,625
1,514,619
1,751,902
1,767,063
1,767,0631,751,9021,514,6191,279,625898,754612,370403,540310,371260,264200,767143,855119,675
       Other Current Assets 
24,187
10,273
18,526
23,577
32,648
56,412
98,415
72,549
90,406
101,807
116,045
113,796
113,796116,045101,80790,40672,54998,41556,41232,64823,57718,52610,27324,187
   > Long-term Assets 
0
0
0
0
0
202,693
460,068
631,784
777,936
978,160
1,051,541
996,888
996,8881,051,541978,160777,936631,784460,068202,69300000
       Property Plant Equipment 
53,143
79,949
95,013
100,312
123,385
161,156
210,901
239,289
246,784
245,391
277,427
233,939
233,939277,427245,391246,784239,289210,901161,156123,385100,31295,01379,94953,143
       Goodwill 
34
34
0
0
0
0
112,912
121,031
154,261
154,644
155,022
142,413
142,413155,022154,644154,261121,031112,91200003434
       Intangible Assets 
8,655
8,419
8,149
7,995
7,752
7,601
7,426
9,046
11,328
32,160
31,323
29,817
29,81731,32332,16011,3289,0467,4267,6017,7527,9958,1498,4198,655
       Long-term Assets Other 
0
0
0
0
0
202,693
9,664
29,991
80,586
119,243
142,268
61,710
61,710142,268119,24380,58629,9919,664202,69300000
> Total Liabilities 
60,253
92,296
91,823
131,580
192,968
233,193
565,618
957,207
1,386,004
2,103,795
2,550,662
2,450,480
2,450,4802,550,6622,103,7951,386,004957,207565,618233,193192,968131,58091,82392,29660,253
   > Total Current Liabilities 
53,292
66,255
70,315
108,034
182,034
206,862
532,401
934,317
1,320,107
1,388,179
1,736,518
1,836,434
1,836,4341,736,5181,388,1791,320,107934,317532,401206,862182,034108,03470,31566,25553,292
       Short-term Debt 
0
0
0
0
0
141,400
286,624
670,535
0
0
0
0
0000670,535286,624141,40000000
       Short Long Term Debt 
0
0
0
0
0
141,400
286,624
670,535
809,210
694,749
690,246
778,870
778,870690,246694,749809,210670,535286,624141,40000000
       Accounts payable 
11,362
21,553
14,661
19,182
25,825
8,460
112,122
127,842
268,843
440,260
583,758
724,882
724,882583,758440,260268,843127,842112,1228,46025,82519,18214,66121,55311,362
       Other Current Liabilities 
28,411
23,752
26,415
27,851
36,011
29,277
83,984
89,413
198,975
205,064
298,194
210,584
210,584298,194205,064198,97589,41383,98429,27736,01127,85126,41523,75228,411
   > Long-term Liabilities 
0
0
0
0
0
26,331
33,218
22,890
65,897
715,617
814,144
614,046
614,046814,144715,61765,89722,89033,21826,33100000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-141,400
-286,624
-670,535
0
27,958
47,476
31,743
31,74347,47627,9580-670,535-286,624-141,40000000
       Long-term Liabilities Other 
0
0
0
0
0
438
326
9,425
50,000
0
0
14,432
14,4320050,0009,42532643800000
       Deferred Long Term Liability 
0
0
0
0
2,288
7,345
30,622
34,587
46,317
41,330
34,017
31,456
31,45634,01741,33046,31734,58730,6227,3452,2880000
> Total Stockholder Equity
251,999
293,663
342,727
399,245
460,705
843,614
933,386
1,520,776
1,489,173
1,647,647
1,562,079
1,402,964
1,402,9641,562,0791,647,6471,489,1731,520,776933,386843,614460,705399,245342,727293,663251,999
   Common Stock
36,580
38,200
38,200
38,200
38,200
50,940
71,316
205,144
205,144
205,027
205,019
203,517
203,517205,019205,027205,144205,14471,31650,94038,20038,20038,20038,20036,580
   Retained Earnings 
82,896
65,825
114,889
171,407
232,867
301,784
391,557
478,584
594,937
636,631
611,458
457,041
457,041611,458636,631594,937478,584391,557301,784232,867171,407114,88965,82582,896
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
2,460
99,346
91,718
96,178
96,17891,71899,3462,46000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,075,614
Cost of Revenue-1,698,360
Gross Profit377,254377,254
 
Operating Income (+$)
Gross Profit377,254
Operating Expense-2,063,242
Operating Income12,371-1,685,989
 
Operating Expense (+$)
Research Development39,998
Selling General Administrative184,995
Selling And Marketing Expenses-
Operating Expense2,063,242224,993
 
Net Interest Income (+$)
Interest Income21,646
Interest Expense-84,561
Other Finance Cost-7,059
Net Interest Income-69,974
 
Pretax Income (+$)
Operating Income12,371
Net Interest Income-69,974
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-203,99112,371
EBIT - interestExpense = -84,561
-153,217
-68,656
Interest Expense84,561
Earnings Before Interest and Taxes (EBIT)--119,430
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-203,991
Tax Provision--14,043
Net Income From Continuing Ops-189,948-189,948
Net Income-153,217
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-69,974
 

Technical Analysis of Thalys
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Thalys. The general trend of Thalys is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Thalys's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Wuhan Thalys Med Tech Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.21 < 7.47 < 11.46.

The bearish price targets are: 5.2.

Tweet this
Wuhan Thalys Med Tech Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Wuhan Thalys Med Tech Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Wuhan Thalys Med Tech Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Wuhan Thalys Med Tech Co Ltd. The current macd is -0.46532767.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Thalys price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Thalys. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Thalys price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Wuhan Thalys Med Tech Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartWuhan Thalys Med Tech Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Wuhan Thalys Med Tech Co Ltd. The current adx is 19.89.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Thalys shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Wuhan Thalys Med Tech Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Wuhan Thalys Med Tech Co Ltd. The current sar is 7.64942478.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Wuhan Thalys Med Tech Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Wuhan Thalys Med Tech Co Ltd. The current rsi is 37.14. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Wuhan Thalys Med Tech Co Ltd Daily Relative Strength Index (RSI) ChartWuhan Thalys Med Tech Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Wuhan Thalys Med Tech Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Thalys price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Wuhan Thalys Med Tech Co Ltd Daily Stochastic Oscillator ChartWuhan Thalys Med Tech Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Wuhan Thalys Med Tech Co Ltd. The current cci is -116.09646298.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Wuhan Thalys Med Tech Co Ltd Daily Commodity Channel Index (CCI) ChartWuhan Thalys Med Tech Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Wuhan Thalys Med Tech Co Ltd. The current cmo is -32.24840792.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Wuhan Thalys Med Tech Co Ltd Daily Chande Momentum Oscillator (CMO) ChartWuhan Thalys Med Tech Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Wuhan Thalys Med Tech Co Ltd. The current willr is -76.99115044.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Thalys is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Wuhan Thalys Med Tech Co Ltd Daily Williams %R ChartWuhan Thalys Med Tech Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Wuhan Thalys Med Tech Co Ltd.

Wuhan Thalys Med Tech Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Wuhan Thalys Med Tech Co Ltd. The current atr is 0.50259695.

Wuhan Thalys Med Tech Co Ltd Daily Average True Range (ATR) ChartWuhan Thalys Med Tech Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Wuhan Thalys Med Tech Co Ltd. The current obv is -251,199,608.

Wuhan Thalys Med Tech Co Ltd Daily On-Balance Volume (OBV) ChartWuhan Thalys Med Tech Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Wuhan Thalys Med Tech Co Ltd. The current mfi is 42.71.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Wuhan Thalys Med Tech Co Ltd Daily Money Flow Index (MFI) ChartWuhan Thalys Med Tech Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Wuhan Thalys Med Tech Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Wuhan Thalys Med Tech Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Wuhan Thalys Med Tech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.137
Ma 20Greater thanMa 507.954
Ma 50Greater thanMa 1007.731
Ma 100Greater thanMa 2009.437
OpenGreater thanClose6.650
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Thalys with someone you think should read this too:
  • Are you bullish or bearish on Thalys? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Thalys? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Wuhan Thalys Med Tech Co Ltd

I send you an email if I find something interesting about Wuhan Thalys Med Tech Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Wuhan Thalys Med Tech Co Ltd.

Receive notifications about Wuhan Thalys Med Tech Co Ltd in your mailbox!